Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

the boots company plc - phenoxymethylpenicillin potassium - oral tablet - 250mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

ivax pharmaceuticals uk ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharma uk ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - phenoxymethylpenicillin potassium - oral tablet - 250mg

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - phenoxymethylpenicillin potassium - oral tablet - 250mg

Estats Units - anglès - NLM (National Library of Medicine)

remedyrepack inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v 250 mg

Estats Units - anglès - NLM (National Library of Medicine)

blenheim pharmacal, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v potassium tablets and penicillin v potassium for oral solution are indicated in the treatment of mild to moderately severe infections due to penicillin g-sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v. streptococcal infections (without bacteremia). mild-to-moderate infections of the upper respiratory tract, scarlet fever, and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus), are resistant. pneumococcal infections. mild to moderately severe infections of the respiratory tract. staphylococcal infections —penicillin g-sensitive. mild infec

Estats Units - anglès - NLM (National Library of Medicine)

redpharm drug, inc. - penicillin v potassium (unii: 146t0tu1jb) (penicillin v - unii:z61i075u2w) - penicillin v potassium tablets, usp and penicillin v potassium for oral solution, usp, are indicated in the treatment of mild to moderately severe infections due to penicillin g- sensitive microorganisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed. the following infections will usually respond to adequate dosage of penicillin v: streptococcal infections (without bacteremia): mild-to-moderate infections of the upper respiratory tract, scarlet fever and mild erysipelas. note: streptococci in groups a, c, g, h, l, and m are very sensitive to penicillin. other groups, including group d (enterococcus) are resistant. pneumococcal infections: mild to moderately severe infections of the respiratory tract. staphylococcal infections - penicillin g se